Back to search
FDAFDA · Food and drugs·Recall number D-243-2013

0.9% Sodium Chloride Injection, USP, 50 mL, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7984-36 Hospira, Inc., Lake Forest, IL 60045

Published April 10, 2013 · Recall initiated: February 18, 2013

Summary

FDA records drug Class II recall D-243-2013, published April 10, 2013 and initiated February 18, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 624,240 units; Lot: Lot #: 22-028-JT Exp 04/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: The product is being recall due to the product lot being incorrectly released without meeting product specifications. There is the potential for the solution to leak from the administrative port to the fill tube seal.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide
Lot
Lot #: 22-028-JT Exp 04/14
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.9% Sodium Chloride Injection, USP, 50 mL, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7984-36 Hospira, Inc., Lake Forest, IL 60045 recalled?

Yes. FDA published recall D-243-2013 on April 10, 2013. Reported hazard: Lack of Assurance of Sterility: The product is being recall due to the product lot being incorrectly released without meeting product specifications. There is the potential for the solution to leak from the administrative port to the fill tube seal.

What should I do if I have this product?

Voluntary: Firm initiated · Letter